SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-19-004571
Filing Date
2019-11-22
Accepted
2019-11-22 12:13:30
Documents
1
Period of Report
2019-10-01

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3256
  Complete submission text file 0001062993-19-004571.txt   4634
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTINE DESIGN LAB 532 BELLA CALAIS WAY SAN JOSE CA 94138
Business Address
CALDWELL PATRICK M (Reporting) CIK: 0001242121 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34236 | Film No.: 191239786